| SC 13G/A | 2024-03-11 | PRICE T ROWE ASSOCIATES INC /MD/ | Avidity Biosciences, Inc. | 9,656,852 | 12.1% | EDGAR |
| SC 13D/A | 2024-03-01 | RTW INVESTMENTS, LP | Avidity Biosciences, Inc. | 9,659,809 | - | EDGAR |
| SC 13G/A | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Avidity Biosciences, Inc. | 6,917,910 | 9.3% | EDGAR |
| SC 13G/A | 2024-02-14 | RA CAPITAL MANAGEMENT, L.P. | Avidity Biosciences, Inc. | 2,454,533 | 3.3% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Avidity Biosciences, Inc. | 4,043,179 | 5.5% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Avidity Biosciences, Inc. | 10,404,096 | 14.0% | EDGAR |
| SC 13G/A | 2024-02-02 | Cowen Financial Products LLC | Avidity Biosciences, Inc. | 5,628,103 | 7.6% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | Avidity Biosciences, Inc. | 6,496,593 | 8.8% | EDGAR |
| SC 13D/A | 2024-01-24 | RTW INVESTMENTS, LP | Avidity Biosciences, Inc. | 6,701,489 | - | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | Avidity Biosciences, Inc. | - | 4.6% | EDGAR |
| SC 13G | 2023-12-04 | BRISTOL MYERS SQUIBB CO | Avidity Biosciences, Inc. | 5,075,304 | 6.4% | EDGAR |
| SC 13G/A | 2023-07-10 | FMR LLC | Avidity Biosciences, Inc. | 10,622,863 | 15.0% | EDGAR |
| SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Avidity Biosciences, Inc. | 6,707,287 | 10.1% | EDGAR |
| SC 13G/A | 2023-02-14 | EcoR1 Capital, LLC | Avidity Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Avidity Biosciences, Inc. | 4,925,377 | 7.4% | EDGAR |
| SC 13G | 2023-02-09 | VANGUARD GROUP INC | Avidity Biosciences, Inc. | 3,470,626 | 5.2% | EDGAR |
| SC 13G/A | 2023-02-03 | BlackRock Inc. | Avidity Biosciences, Inc. | 5,286,174 | 8.0% | EDGAR |
| SC 13G | 2023-02-03 | STATE STREET CORP | Avidity Biosciences, Inc. | - | 5.4% | EDGAR |
| SC 13D/A | 2023-02-02 | RTW INVESTMENTS, LP | Avidity Biosciences, Inc. | 5,956,558 | - | EDGAR |
| SC 13G/A | 2023-01-11 | Cowen Financial Products LLC | Avidity Biosciences, Inc. | 5,188,366 | 6.4% | EDGAR |